LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate
LCP-Tacro Heads into US Phase II Clinical Trials for Organ Transplantation
04-Jun-2007 -
LifeCycle Pharma A/S announced positive results from its Phase I clinical trial program of LCP-Tacro, a proprietary, once-daily tacrolimus tablet. A series of Phase I trials, involving more than 150 healthy volunteers demonstrate that LCP-Tacro has a once-daily profile, delivers consistently ...
bioavailability
clinical trials
organ transplantation
+2